| Literature DB >> 31930112 |
Dongye He1, Shu Jia1, Yongping Xu2.
Abstract
Camellia euphlebia is a new food source and traditional folk medicine in China. Previous studies have demonstrated the antidepressant activity of Camellia euphlebia extract by both in vivo and in vitro experiments. The effects of different pretreatments on phytochemical contents and neuroprotective activity of Camellia euphlebia extract were further investigated in order to develop an optimal processing method that makes the extraction more efficient. Six different powders of Camellia euphlebia leaves were prepared by different pretreatments. The particle size and morphology were examined by using a Malvern particle size analyzer and scanning electron microscopy, respectively. The results showed that the percentage of powder particle size within a range of 0.2∼40 μm was up to 79.18% after press-shear assisted interaction technology pretreatment by 2% addition of shellfish shell powder, and the cells were broken completely. Additionally, the contents of flavonoids, polysaccharides, polyphenols, saponins, and catechin in the extract were 11.78 ± 0.62%, 34.60 ± 3.37%, 6.15 ± 0.29%, 9.43 ± 1.19%, and 1.99 ± 0.11%, respectively, which were higher than those of the other five extracts. Moreover, the extract had the strongest neuroprotective activity by comparing the neuroprotective effect of different extracts on corticosterone-induced neurotoxicity in differentiated PC12 cells. It is concluded that press-shear assisted interaction technology with 2% addition of shellfish shell powder pretreatment, to a great extent, improved the dissolution of bioactive ingredients in Camellia euphlebia.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31930112 PMCID: PMC6942713 DOI: 10.1155/2019/1717090
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Particle size distribution of leaves powder from Camellia euphlebia processed by different pretreatments.
| Sample | Sample size distribution (%) | ||
|---|---|---|---|
| 0.2–40 | 40–200 | 200–1000 | |
| 60 mesh | 21.31 | 42.39 | 36.30 |
| 200 mesh | 62.00 | 38.00 | 0.00 |
| PS | 65.20 | 34.74 | 0.06 |
| PAI-1 | 68.42 | 28.70 | 2.88 |
| PAI-2 | 79.18 | 20.74 | 0.08 |
| PAI-4 | 77.81 | 21.69 | 0.50 |
PS: press shear technology; PAI: press-shear assisted interaction technology.
Figure 1Particle size distribution of leaves powder from Camellia euphlebia powder processed by different pretreatments. PAI: press-shear assisted interaction technology.
Figure 2SEM micrographs of Camellia euphlebia processed by different procedures: (a) 60 mesh powder; (b) 200 mesh powder; (c) PS powder; (d) PAI-1 powder; (e) PAI-2 powder; (f) PAI-4 powder. PS: press shear technology; PAI: press-shear assisted interaction technology.
: Comparison of the major components of aqueous extracts processed by different pretreatments.
| Samples | Yield of extracts (%) | Phytochemical contents (%) | ||||
|---|---|---|---|---|---|---|
| Flavonoids | Polyphenols | Saponins | Polysaccharides | Catechin | ||
| 60 mesh | 10.40 ± 0.79a | 4.74 ± 0.68a | 2.64 ± 0.71a | 5.09 ± 0.80a | 18.50 ± 1.50a | 0.53 ± 0.04a |
| 200 mesh | 11.93 ± 0.40b | 6.67 ± 0.18ab | 5.59 ± 0.93b | 7.40 ± 0.78ab | 25.40 ± 1.98ab | 1.33 ± 0.07b |
| PS | 12.83 ± 0.57b | 8.27 ± 1.18bc | 3.72 ± 0.73a | 7.22 ± 0.0.90ab | 24.85 ± 3.34ab | 1.54 ± 0.09bc |
| PAI-1 | 16.90 ± 0.44c | 8.05 ± 0.82bc | 5.45 ± 0.52b | 7.65 ± 0.93ab | 30.93 ± 5.09bc | 1.40 ± 0.08bc |
| PAI-2 | 18.93 ± 0.25d | 11.78 ± 0.62d | 6.15 ± 0.29b | 9.43 ± 1.19b | 34.60 ± 3.37c | 1.99 ± 0.11d |
| PAI-3 | 15.73 ± 0.60c | 5.11 ± 0.46a | 5.75 ± 0.60b | 6.26 ± 1.01a | 27.10 ± 3.08abc | 1.57 ± 0.0.05c |
The values are expressed as mean ± SEM from triplicate assays. Within each row, values with different superscripts are significantly different from each other (P < 0.05), as determined by Tukey's t-test. PS: press shear technology; PAI: press-shear assisted interaction technology.
Figure 3Effect of six extracts on cell viability in differentiated PC12 cells. Results are presented as means ± SEM (n = 5). P < 0.001 as compared with control group. (a) 60 mesh extract; (b) 200 mesh extract; (c) PS powder extract; (d) PAI (1%) powder extract; (e) PAI (2%) powder extract; (f) PAI (4%) powder extract.
Figure 4Effect of six extracts on cell viability in corticosterone-treated differentiated PC12 cells by MTT assay. ###P < 0.001 as compared with control group; P < 0.05, P < 0.01, or P < 0.001 as compared with corticosterone-treated group. (a) 60 mesh extract; (b) 200 mesh extract; (c) PS powder extract; (d) PAI-1 powder extract; (e) PAI-2 powder extract; (f) PAI-4 powder extract.